Find clinical trials for Non-Hodgkin Lymphoma in Louisville, KY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Louisville, KY, USA:
Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...
Phase 1, Phase 2
Louisville, Kentucky, United States and 31 other locations
CB010A is a study evaluating safety, emerging efficacy, pharmacokinetics and immunogenicity of CB-010 in adults with relapsed/refractory B cell non...
Phase 1
Louisville, Kentucky, United States and 37 other locations
drugs less effective or could lead to side effects)* To find out how well the study drugs work against relapsed or refractory aggressive B-cell non...
Phase 1
Louisville, Kentucky, United States and 19 other locations
clinical trial will enroll patients with relapsed/refractory non-Hodgkin lymphoma of B-cell origin and is conducted in two...
Phase 1, Phase 2
Louisville, Kentucky, United States and 22 other locations
pharmacokinetic, pharmacodynamic, and clinical activity of AZD0486, a CD19 x CD3 T-cell engaging bispecific antibody, in subjects with B-cell non...
Phase 1
Louisville, Kentucky, United States and 28 other locations
chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggressive large B-cell lymphoma....
Phase 1, Phase 2
Louisville, Kentucky, United States and 16 other locations
This study is researching an investigational drug, odronextamab, in adult patients B-cell non-Hodgkin's lymphoma (B-NHL).T...
Phase 2
Louisville, Kentucky, United States and 140 other locations
with or without Acalabrutinib in Subjects with Indolent B-Cell Non-Hodgkin Lymphoma That has Relapsed or is Refractory to ...
Phase 1, Phase 2
Louisville, Kentucky, United States and 26 other locations
20-expressing Non-Hodgkin lymphoma....
Phase 1
Louisville, Kentucky, United States and 12 other locations
in combination with bendamustine and rituximab (BR) compared with placebo plus BR in subjects with previously untreated mantle cell lymphoma....
Phase 3
Louisville, Kentucky, United States and 227 other locations
Clinical trials
Research sites
Resources
Legal